These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 3362878

  • 1. Applications of the xenograft as a model of invasive transitional cell carcinoma of the bladder.
    Russell PJ, Raghavan D, Philips J, Gregory P.
    Prog Clin Biol Res; 1988; 260():167-81. PubMed ID: 3362878
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice.
    Reid LM, Leav I, Kwan PW, Russell P, Merk FB.
    Cancer Res; 1984 Oct; 44(10):4560-73. PubMed ID: 6467211
    [Abstract] [Full Text] [Related]

  • 3. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)].
    Li C, Yan RP, Yuan GH, Feng YG, Wang JS, Gao X, Huang YS, Zhou JB, Xie SS.
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782
    [Abstract] [Full Text] [Related]

  • 4. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D, Ramos-Vara JA, Stewart JC, Zheng R, Knapp DW.
    Urol Oncol; 2009 Oct; 27(3):284-92. PubMed ID: 18562222
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 8. [Chemosensitivity test for bladder cancer in a nude-mice experimental system].
    Yamauchi T, Okada K, Yoshida O, Kawai T.
    Hinyokika Kiyo; 1986 Dec; 32(12):1949-58. PubMed ID: 3825832
    [Abstract] [Full Text] [Related]

  • 9. Magnetic resonance imaging of response to chemotherapy in orthotopic xenografts of human bladder cancer.
    Mazurchuk R, Glaves D, Raghavan D.
    Clin Cancer Res; 1997 Sep; 3(9):1635-41. PubMed ID: 9815854
    [Abstract] [Full Text] [Related]

  • 10. Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion.
    Fujiyama C, Jones A, Fuggle S, Bicknell R, Cranston D, Harris AL.
    Br J Cancer; 2001 Feb; 84(4):558-64. PubMed ID: 11207054
    [Abstract] [Full Text] [Related]

  • 11. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [Abstract] [Full Text] [Related]

  • 12. Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide.
    Dinney CP, Parker C, Dong Z, Fan D, Eve BY, Bucana C, Radinsky R.
    Clin Cancer Res; 1997 Feb; 3(2):161-8. PubMed ID: 9815668
    [Abstract] [Full Text] [Related]

  • 13. Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents.
    Huland E, Arndt R, Huland H.
    Cancer Res; 1986 May; 46(5):2488-9. PubMed ID: 3697989
    [Abstract] [Full Text] [Related]

  • 14. Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given?
    Bouffioux C.
    Prog Clin Biol Res; 1985 May; 185B():47-55. PubMed ID: 4034591
    [No Abstract] [Full Text] [Related]

  • 15. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM.
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New developments in first- and second-line chemotherapy for transitional cell, squamous cell and adenocarcinoma of the bladder.
    De Santis M, Bachner M.
    Curr Opin Urol; 2007 Sep; 17(5):363-8. PubMed ID: 17762632
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of the platinum analog [Pt(cis-dach)(DPPE)-2NO3] on histocultured human patient bladder tumors and cancer cell lines.
    Chang SG, Jung JC, Rho YS, Huh JS, Kim JI, Hoffman RM.
    Anticancer Res; 1996 Sep; 16(6B):3423-8. PubMed ID: 9042201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.